Stem cell therapy for early Alzheimer's disease
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a stem cell treatment for people with early-stage Alzheimer's disease. It aims to see if the treatment can help slow memory loss or other symptoms. You must have a specific blood test showing inflammation in the body to qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 60 and 80 years old
- Have been diagnosed with mild cognitive impairment or very early Alzheimer's
- Have a positive brain scan or spinal fluid test for amyloid plaques
- Have a blood test showing signs of inflammation (like high CRP or IL-6 levels)
- Must be able to speak English fluently
- Must be willing to have blood tests, brain scans, and spinal taps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive magnetic brain stimulation technique can help improve memory in people with early Alzheimer's disease. It may be an option if you have mild cognitive impairment or mild dementia due to Alzheimer's and have had a positive blood test for Alzheimer's markers.
This study tests whether human stem cells, combined with your existing Alzheimer's medication (Leqembi or Kisunla), can help slow memory loss and improve daily functioning in people with mild cognitive impairment or early Alzheimer's. You would receive a stem cell infusion as an add-on to your current treatment.
This trial studies a new treatment for people with mild to moderate Alzheimer's disease. They take your own fat cells, turn them into stem cells, and inject them into the fluid around your brain. The hope is that these cells may help slow down memory loss.
This trial tests whether stem cells from donated fat tissue can help people with mild to moderate Alzheimer's disease. It combines infusions of these cells with standard care, and includes brain scans and memory tests to see if the treatment is safe and effective.
This study tests a new treatment using tiny particles from stem cells (called exosomes) given as a nasal spray. It aims to see if it can help people with early-onset Alzheimer's disease, which starts before age 65.
This study tests a new approach for people with mild memory problems using stem cell therapy and a wearable brain-computer device. The goal is to see if these treatments can help improve or slow down memory decline.
Hear when a new Cognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.